Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Kathleen J. Jirgens"'
Autor:
Anita Krishnamurthy, Meryl Brod, Clayton R. Rowland, Kathleen J. Jirgens, Shoshana S. Colman, Baltazar Gomez-Mancilla
Publikováno v:
Clinical Therapeutics. 23:127-145
Background: Patient-reported outcomes, such as treatment satisfaction, functional status, and health-related quality of life (HRQOL) are essential components of migraine research. Almotriptan is a new selective serotonin 1B/1D agonist triptan migrain
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00e13618d35da394313f4fbf1dfaf543
https://doi.org/10.1016/s0149-2918(01)80036-9
https://doi.org/10.1016/s0149-2918(01)80036-9
Autor:
Clayton R. Rowland, Kathleen J. Jirgens, Fredrick S. Whaley, Daniel E. Grosz, Baltazar Gomez-Mancilla, Egilius L.H. Spierings
Publikováno v:
Archives of Neurology. 58:944
Background Almotriptan malate is a novel, selective serotonin 1B/D agonist, or triptan, developed for the abortive treatment of migraine. In double-blind, placebo-controlled studies, it has been shown to be effective, well tolerated, and safe. Object
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2960404e3648878f060ce0eb391e878
https://doi.org/10.1001/archneur.58.6.944
https://doi.org/10.1001/archneur.58.6.944